Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel drug targets and therapeutics for Parkinson's disease. The partnership ...

If you could see past the dry ice and lasers the Valo, the aircraft Vertical Aerospace intends to bring to market, was surprisingly beautiful. The rough edges – metaphorical and literal – of the VX4 ...

It's not so much about creating large-scale physical infrastructure of the eVTOL realm (after all, the whole point of Electric Vertical Take-off and Landing is low noise, small footprint), but about ...

For the past several years, a British company called Vertical Aerospace has been working to put together what may very well become Europe's first-ever operational electric vertical take-off and ...

Vertical Aerospace has unveiled Valo, the certification-intent version of its VX4 prototype, which features multiple updates, including aerodynamic improvements, over its predecessor. UK-headquartered ...

A significantly enhanced design built on the successes of the VX4 prototype test programme A flexible, premium cabin for up to 6 passengers with class-leading luggage capacity Engineered to meet the ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health, Inc. (“Valo”), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Rita ...

Flagship Pioneering collaborates with ProFound and Quotient to explore novel protein drug targets for COPD, IPF, and MASH using advanced platforms. GSK has the option to further develop ProFound and ...

Grupo Financiero Valores S.A. FRANKFURT, Nov 20 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration ...

FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially ...

Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders Partnership includes upfront and ...

LEXINGTON, Mass., November 20, 2025--(BUSINESS WIRE)--Valo Health, Inc. ("Valo"), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced a ...